Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.

Name: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial.
Author: Rivera, Fernando

Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trial. — المؤلف: Rivera, Fernando — Cancer chemotherapy and pharmacology 20200303

المؤلف: Rivera, Fernando
النشر: Cancer chemotherapy and pharmacology 20200303
الوصف: 1175-1181 p.
الموضوعات: Adult؛ Aged؛ Aged, 80 and over؛ Antineoplastic Combined Chemotherapy Protocols؛ Capecitabine؛ Deoxycytidine؛ Esophagogastric Junction؛ Female